Bruker Corporation

BRKR Healthcare Medical Devices

Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024.

Revenue
+1.57%
EPS
−75.4%
Free cash flow
+278.7%
Total debt
−14.7%

Quarter to September 2026, against a year earlier

61.20 3.14 +5.41%
Market cap
$8.9B
P/E
0.0×
Fwd P/E
−412×
Dividend yield
0.33%
F-score
4/9
Altman Z
2.43
Beneish M
−2.56
Dividend safety
34/100
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
22.72 69.04 25.89 39.82 52.55 45.85 34.54 24.76 77.13 0.00
Piotroski F-Score
7 7 7 6 5 8 5 6 3 4
Altman Z-Score
4.25 5.15 4.70 4.81 4.41 5.15 4.69 4.33 2.77 2.43
P/S ratio
2.16 3.09 2.45 3.82 4.18 5.25 4.06 3.57 2.59 2.08
P/FCF ratio
29.12 37.13 21.56 44.90 31.94 57.72 55.81 39.50 54.32 105.01
Altman Z″-Score (non-manufacturers)
5.65 5.78 5.47 5.47 4.98 5.44 5.20 4.47 2.99 2.98
Beneish M-Score
(2.41) (2.37) (2.26) (2.60) (2.79) (2.38) (2.20) (2.23) (2.28) (2.56)
P/Operating CF
38.36 52.63 35.15 58.08 40.90 91.66 59.85 51.51 45.97 31.12
Dividend Safety Score
— — — — — — — — — 34
P/B ratio
5.03 7.44 5.14 8.63 8.52 11.71 9.12 7.59 4.86 2.89
EV/Sales
2.11 3.08 2.46 3.88 4.23 5.32 4.28 3.84 3.16 2.54
EV/EBITDA
14.38 19.17 14.26 21.35 25.60 25.62 20.78 20.62 24.37 30.23
EV/FCF
28.38 36.97 21.64 45.62 32.37 58.47 58.93 42.45 66.20 128.07
Current Ratio
2.43 2.59 2.18 2.78 2.43 2.63 2.31 1.80 1.60 1.73
Net Debt/EBITDA
(0.38) (0.08) 0.06 0.34 0.34 0.33 1.10 1.44 4.37 5.44
Debt/Equity
0.59 0.57 0.38 0.89 0.87 1.23 1.08 0.92 1.17 0.76
ROE
21.54% 11.02% 21.93% 21.64% 16.69% 26.92% 26.84% 33.90% 7.09% (1.05%)
ROA
8.68% 4.18% 8.82% 8.05% 5.42% 8.27% 8.17% 10.87% 2.25% (0.37%)
ROIC
18.80% 19.32% 17.75% 17.99% 14.28% 20.66% 15.91% 12.48% 4.27% 1.05%
Return on Tangible Assets
15.51% 7.14% 18.42% 13.54% 10.32% 14.29% 17.59% 27.35% 7.85% (1.34%)
Average Days of Receivables
55.25 66.00 68.78 63.79 61.58 62.93 68.18 60.58 61.31 57.88
Earnings Yield
4.40% 1.45% 3.86% 2.51% 1.90% 2.18% 2.90% 4.04% 1.30% (0.32%)
Free Cash Flow Yield
3.43% 2.69% 4.64% 2.23% 3.13% 1.73% 1.79% 2.53% 1.84% 0.95%
Free Cash Flow per Share
0.59 0.77 1.22 0.98 1.53 1.29 1.07 1.66 0.91 0.29
Book value per Share
4.29 4.64 5.79 5.91 6.35 7.16 7.58 9.53 12.06 16.29
Free Cash Flow
94.80 122.20 190.90 151.40 235.20 195.30 159.10 243.20 136.00 43.30
EV/EBIT
18.67 24.76 17.79 26.72 33.90 31.14 25.05 26.04 42.06 127.88
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026